Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane

被引：0
|
作者：
Motoo Nomura
Satoru Iwasa
Takahiro Tsushima
Ken Kato
Hirofumi Yasui
Narikazu Boku
Manabu Muto
Kei Muro
机构：
[1] Aichi Cancer Center Hospital,Department of Clinical Oncology
[2] Kyoto University Graduate School of Medicine,Department of Therapeutic Oncology
[3] National Cancer Center Hospital,Division of Gastrointestinal Medical Oncology
[4] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Esophageal cancer; Metastasis; Best supportive care; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1209 / 1216
页数：7
相关论文
共 50 条
  • [31] Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinoma
    Li, Ying
    Ji, Yanyan
    Shen, Lin
    Yin, Xudong
    Huang, Tianyu
    Deng, Bin
    Guo, Hong
    Wu, Yunjiang
    Chen, Yong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] CISPLATIN AND 5-FLUOROURACIL AS SALVAGE THERAPY FOR RECURRENT METASTATIC SQUAMOUS-CELL CARCINOMA OF THE ANAL-CANAL
    JAIYESIMI, IA
    PAZDUR, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (06): : 536 - 540
  • [33] Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus
    Ojima, Toshiyasu
    Nakamori, Mikihito
    Nakamura, Masaki
    Katsuda, Masahiro
    Hayata, Keiji
    Kato, Tomoya
    Kitadani, Junya
    Tabata, Hirotaka
    Takeuchi, Akihiro
    Iwahashi, Makoto
    Yamaue, Hiroki
    ANTICANCER RESEARCH, 2016, 36 (02) : 829 - 834
  • [34] A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma
    Bauman, Julie E.
    Arias-Pulido, Hugo
    Lee, Sang-Joon
    Fekrazad, M. Houman
    Ozawa, Hiroyuki
    Fertig, Elana
    Howard, Jason
    Bishop, Justin
    Wang, Hao
    Olson, Garth T.
    Spafford, Michael J.
    Jones, Dennie V.
    Chung, Christine H.
    ORAL ONCOLOGY, 2013, 49 (05) : 461 - 467
  • [35] Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Zenda, Sadamoto
    Onozawa, Yusuke
    Boku, Narikazu
    Fida, Yoshiyuki
    Ebihara, Mitsuru
    Onitsuka, Tetsuro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (07) : 477 - 481
  • [36] Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/mHNSCC)
    Prithviraj, T.
    ORAL ONCOLOGY, 2024, 158
  • [37] Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Wakasaki, Takahiro
    Yasumatsu, Ryuji
    Masuda, Muneyuki
    Takeuchi, Toranoshin
    Manako, Tomomi
    Matsuo, Mioko
    Jiromaru, Rina
    Uchi, Ryutaro
    Komune, Noritaka
    Noda, Teppei
    Nakagawa, Takashi
    CANCERS, 2020, 12 (08) : 1 - 11
  • [38] Capecitabine and cisplatin combination chemotherapy as salvage therapy for recurrent unresectable or metastatic squamous cell carcinoma of the head and neck
    Chung, J.
    Cho, G.
    Shin, H.
    Choi, Y.
    Lee, S.
    Lee, B.
    Wang, S.
    Lee, M.
    Sohn, C.
    Yang, Y.
    EJC SUPPLEMENTS, 2005, 3 (02): : 297 - 297
  • [39] A phase I/II study of divided- dose docetaxel, cisplatin, and fluorouracil (DCF) for patients with recurrent or metastatic squamous cell carcinoma of the esophagus
    Ojima, Toshiyasu
    Nakamori, Mikihito
    Nakamura, Masaki
    Iwahashi, Makoto
    Katsuda, Masahiro
    Hayata, Keiji
    Matsumura, Shuichi
    Yamaue, Hiroki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [40] Radiomic features in recurrent/metastatic platinum refractory head and neck squamous cell carcinoma treated with immunotherapy.
    Anile, Giuseppe
    Bettinelli, Andrea
    Paiusco, Marta
    De Conti, Giorgio
    Gottardi, Chiara
    Conte, Pierfranco
    Ghi, Maria Grazia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345